1. Home
  2. LEXX vs FPAY Comparison

LEXX vs FPAY Comparison

Compare LEXX & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • FPAY
  • Stock Information
  • Founded
  • LEXX 2004
  • FPAY 2003
  • Country
  • LEXX Canada
  • FPAY United States
  • Employees
  • LEXX N/A
  • FPAY N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • LEXX Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • LEXX 16.5M
  • FPAY 18.3M
  • IPO Year
  • LEXX N/A
  • FPAY N/A
  • Fundamental
  • Price
  • LEXX $1.30
  • FPAY $0.82
  • Analyst Decision
  • LEXX Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • LEXX 1
  • FPAY 2
  • Target Price
  • LEXX $4.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • LEXX 193.3K
  • FPAY 192.9K
  • Earning Date
  • LEXX 07-14-2025
  • FPAY 11-12-2025
  • Dividend Yield
  • LEXX N/A
  • FPAY N/A
  • EPS Growth
  • LEXX N/A
  • FPAY N/A
  • EPS
  • LEXX N/A
  • FPAY N/A
  • Revenue
  • LEXX $615,923.00
  • FPAY $139,800,732.00
  • Revenue This Year
  • LEXX $46.98
  • FPAY $19.71
  • Revenue Next Year
  • LEXX $17.26
  • FPAY N/A
  • P/E Ratio
  • LEXX N/A
  • FPAY N/A
  • Revenue Growth
  • LEXX 49.85
  • FPAY 19.51
  • 52 Week Low
  • LEXX $0.77
  • FPAY $0.45
  • 52 Week High
  • LEXX $3.47
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 76.03
  • FPAY 57.37
  • Support Level
  • LEXX $0.98
  • FPAY $0.66
  • Resistance Level
  • LEXX $1.34
  • FPAY $0.74
  • Average True Range (ATR)
  • LEXX 0.09
  • FPAY 0.08
  • MACD
  • LEXX 0.04
  • FPAY 0.03
  • Stochastic Oscillator
  • LEXX 91.72
  • FPAY 57.92

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: